NEW YORK, April 10 - The worldwide market for microarrays, microfluidics devices, and other biochips is expected to grow at an annual growth rate of 65 percent and reach $3.3 billion by 2004, a new report by market research firm Frost & Sullivan says. 

The report, a preview of which was obtained by GenomeWeb prior to its release later this month, outlines the way in which the market for microarrays, microfluidic devices, and other biochips is likely to develop in the next three years. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.